374 related articles for article (PubMed ID: 37595264)
1. Sex-biased TGFβ signalling in pulmonary arterial hypertension.
Wits M; Becher C; de Man F; Sanchez-Duffhues G; Goumans MJ
Cardiovasc Res; 2023 Oct; 119(13):2262-2277. PubMed ID: 37595264
[TBL] [Abstract][Full Text] [Related]
2. TGFβ and BMPRII signalling pathways in the pathogenesis of pulmonary arterial hypertension.
Tielemans B; Delcroix M; Belge C; Quarck R
Drug Discov Today; 2019 Mar; 24(3):703-716. PubMed ID: 30529762
[TBL] [Abstract][Full Text] [Related]
3. The transforming growth factor-β-bone morphogenetic protein type signalling pathway in pulmonary vascular homeostasis and disease.
Upton PD; Morrell NW
Exp Physiol; 2013 Aug; 98(8):1262-6. PubMed ID: 23645549
[TBL] [Abstract][Full Text] [Related]
4. BMPR-II deficiency elicits pro-proliferative and anti-apoptotic responses through the activation of TGFβ-TAK1-MAPK pathways in PAH.
Nasim MT; Ogo T; Chowdhury HM; Zhao L; Chen CN; Rhodes C; Trembath RC
Hum Mol Genet; 2012 Jun; 21(11):2548-58. PubMed ID: 22388934
[TBL] [Abstract][Full Text] [Related]
5. BMPR2 acts as a gatekeeper to protect endothelial cells from increased TGFβ responses and altered cell mechanics.
Hiepen C; Jatzlau J; Hildebrandt S; Kampfrath B; Goktas M; Murgai A; Cuellar Camacho JL; Haag R; Ruppert C; Sengle G; Cavalcanti-Adam EA; Blank KG; Knaus P
PLoS Biol; 2019 Dec; 17(12):e3000557. PubMed ID: 31826007
[TBL] [Abstract][Full Text] [Related]
6. BMPR2 mutation in a patient with pulmonary arterial hypertension and suspected hereditary hemorrhagic telangiectasia.
Rigelsky CM; Jennings C; Lehtonen R; Minai OA; Eng C; Aldred MA
Am J Med Genet A; 2008 Oct; 146A(19):2551-6. PubMed ID: 18792970
[TBL] [Abstract][Full Text] [Related]
7. Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertension.
Gomez-Puerto MC; van Zuijen I; Huang CJ; Szulcek R; Pan X; van Dinther MA; Kurakula K; Wiesmeijer CC; Goumans MJ; Bogaard HJ; Morrell NW; Rana AA; Ten Dijke P
J Pathol; 2019 Nov; 249(3):356-367. PubMed ID: 31257577
[TBL] [Abstract][Full Text] [Related]
8. The BMP Receptor 2 in Pulmonary Arterial Hypertension: When and Where the Animal Model Matches the Patient.
Happé C; Kurakula K; Sun XQ; da Silva Goncalves Bos D; Rol N; Guignabert C; Tu L; Schalij I; Wiesmeijer KC; Tura-Ceide O; Vonk Noordegraaf A; de Man FS; Bogaard HJ; Goumans MJ
Cells; 2020 Jun; 9(6):. PubMed ID: 32521690
[No Abstract] [Full Text] [Related]
9. Codependence of Bone Morphogenetic Protein Receptor 2 and Transforming Growth Factor-β in Elastic Fiber Assembly and Its Perturbation in Pulmonary Arterial Hypertension.
Tojais NF; Cao A; Lai YJ; Wang L; Chen PI; Alcazar MAA; de Jesus Perez VA; Hopper RK; Rhodes CJ; Bill MA; Sakai LY; Rabinovitch M
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1559-1569. PubMed ID: 28619995
[TBL] [Abstract][Full Text] [Related]
10. MED1 Regulates BMP/TGF-β in Endothelium: Implication for Pulmonary Hypertension.
Wang C; Xing Y; Zhang J; He M; Dong J; Chen S; Wu H; Huang HY; Chou CH; Bai L; He F; She J; Su A; Wang Y; Thistlethwaite PA; Huang HD; Yuan JX; Yuan ZY; Shyy JY
Circ Res; 2022 Oct; 131(10):828-841. PubMed ID: 36252121
[TBL] [Abstract][Full Text] [Related]
11. Genetics and genomics of pulmonary arterial hypertension.
Soubrier F; Chung WK; Machado R; Grünig E; Aldred M; Geraci M; Loyd JE; Elliott CG; Trembath RC; Newman JH; Humbert M
J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D13-21. PubMed ID: 24355637
[TBL] [Abstract][Full Text] [Related]
12. BMPR2 gene therapy for PAH acts via Smad and non-Smad signalling.
Harper RL; Reynolds AM; Bonder CS; Reynolds PN
Respirology; 2016 May; 21(4):727-33. PubMed ID: 26809239
[TBL] [Abstract][Full Text] [Related]
13. Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease.
Long L; Crosby A; Yang X; Southwood M; Upton PD; Kim DK; Morrell NW
Circulation; 2009 Feb; 119(4):566-76. PubMed ID: 19153267
[TBL] [Abstract][Full Text] [Related]
14. At the X-Roads of Sex and Genetics in Pulmonary Arterial Hypertension.
Cirulis MM; Dodson MW; Brown LM; Brown SM; Lahm T; Elliott G
Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33233517
[TBL] [Abstract][Full Text] [Related]
15. Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal Transformation.
Tian W; Jiang X; Sung YK; Shuffle E; Wu TH; Kao PN; Tu AB; Dorfmüller P; Cao A; Wang L; Peng G; Kim Y; Zhang P; Chappell J; Pasupneti S; Dahms P; Maguire P; Chaib H; Zamanian R; Peters-Golden M; Snyder MP; Voelkel NF; Humbert M; Rabinovitch M; Nicolls MR
Circulation; 2019 Oct; 140(17):1409-1425. PubMed ID: 31462075
[TBL] [Abstract][Full Text] [Related]
16. BMPR2 gene delivery reduces mutation-related PAH and counteracts TGF-β-mediated pulmonary cell signalling.
Feng F; Harper RL; Reynolds PN
Respirology; 2016 Apr; 21(3):526-32. PubMed ID: 26689975
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic pulmonary hypertension: what did we learn from genes?
Sztrymf B; Yaïci A; Jaïs X; Sitbon O; Simonneau G; Humbert M
Sarcoidosis Vasc Diffuse Lung Dis; 2005 Dec; 22 Suppl 1():S91-100. PubMed ID: 16457021
[TBL] [Abstract][Full Text] [Related]
18. The role of TGF-β or BMPR2 signaling pathway-related miRNA in pulmonary arterial hypertension and systemic sclerosis.
Xu B; Xu G; Yu Y; Lin J
Arthritis Res Ther; 2021 Nov; 23(1):288. PubMed ID: 34819148
[TBL] [Abstract][Full Text] [Related]
19. Targeted gene delivery of BMPR2 attenuates pulmonary hypertension.
Reynolds AM; Holmes MD; Danilov SM; Reynolds PN
Eur Respir J; 2012 Feb; 39(2):329-43. PubMed ID: 21737550
[TBL] [Abstract][Full Text] [Related]
20. The Role of Bone Morphogenetic Protein Receptor Type 2 (
Devendran A; Kar S; Bailey R; Trivieri MG
Cells; 2022 Nov; 11(23):. PubMed ID: 36497082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
